Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Sofie VetsRik Gijsbers

Abstract

Lens epithelium-derived growth factor (LEDGF/p75) is an essential cofactor of HIV integration. Both stable overexpression of the C-terminal part of LEDGF/p75 (LEDGF(325-530)) containing the integrase (IN)-binding domain (IBD) and stable knockdown (KD) of LEDGF/p75 are known to inhibit HIV infection in laboratory cell lines. Here, primary human CD(4)(+) T-cells were transduced with lentiviral vectors encoding LEDGF(325-530), the interaction-deficient mutant LEDGF(325-530)D366N, or a hairpin depleting LEDGF/p75 and challenged with HIV. Maximal protection of primary T-cells from HIV infection was obtained after LEDGF(325-530) overexpression reducing HIV replication 40-fold without evidence of cellular toxicity. This strategy was subsequently evaluated in the NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) mouse model. Threefold reduction in mean plasma viral load was obtained in mice engrafted with CD(4)(+) T-cells expressing LEDGF(325-530) in comparison with engraftment with LEDGF(325-530)D366N cells. Four weeks after transplantation with LEDGF(325-530)D366N cells, 70% of the CD(4)(+) cells were lost due to ongoing HIV replication. However, in mice transplanted with LEDGF(325-530) cells only a 20% decrease in CD(4)(+) cells was measur...Continue Reading

References

Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·B FehseC Baum
Oct 31, 2002·The Journal of Biological Chemistry·Peter CherepanovZeger Debyser
Mar 8, 2005·The Journal of Biological Chemistry·Katrien BusschotsZeger Debyser
May 17, 2005·Nature Structural & Molecular Biology·Peter CherepanovAlan Engelman
May 21, 2005·The Journal of Gene Medicine·Martine GeraertsRik Gijsbers
Nov 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peter CherepanovAlan Engelman
Jan 13, 2006·Trends in Biochemical Sciences·Bénédicte Van MaeleZeger Debyser
Jan 19, 2006·The Journal of Experimental Medicine·William G GlassPhilip M Murphy
Sep 9, 2006·Science·Manuel LlanoEric M Poeschla
Apr 3, 2007·PLoS Pathogens·Anneleen HombrouckZeger Debyser
May 9, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Daniel BodenBharat Ramratnam
Aug 3, 2007·Journal of Molecular Biology·Koen BartholomeeusenFrauke Christ
Jul 5, 2008·Cancer Cell·Akihiko Yokoyama, Michael L Cleary
Sep 20, 2008·The Journal of Biological Chemistry·Christopher J McKeeMamuka Kvaratskhelia
Dec 3, 2008·Handbook of Experimental Pharmacology·D von LaerU Protzer
Feb 14, 2009·The New England Journal of Medicine·Gero HütterEckhard Thiel
Feb 27, 2009·The Journal of Biological Chemistry·Koen BartholomeeusenJan De Rijck
May 1, 2006·Current Opinion in HIV and AIDS·Paul Spearman
Sep 11, 2009·The Journal of Clinical Investigation·Martha R NeaguJeremy Luban
Dec 17, 2009·Current Topics in Microbiology and Immunology·Manuel LlanoEric M Poeschla
Dec 29, 2009·American Journal of Obstetrics and Gynecology·Philipp KlaritschJan A Deprest
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrea L FerrisStephen H Hughes
Mar 3, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rik GijsbersZeger Debyser
Jan 19, 2011·Current Opinion in HIV and AIDS·Paula Cannon, Carl June
Jan 21, 2011·Virology·Scott G KitchenDong Sung An
Jul 19, 2011·Journal of Molecular Biology·Melissa McNeelyZeger Debyser

❮ Previous
Next ❯

Citations

Jul 26, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Belete A DesimmieFrauke Christ
Jul 10, 2012·Nature Structural & Molecular Biology·Mads DaugaardMarja Jäättelä
May 23, 2014·Molecular Biotechnology·Ye LiuDeyin Guo
Dec 20, 2013·Viruses·Michael S Bennett, Ramesh Akkina
Mar 27, 2015·Retrovirology·Belete Ayele DesimmieZeger Debyser
Sep 19, 2012·Current Opinion in Immunology·John C BurnettJohn J Rossi
Feb 4, 2016·Oncotarget·Juliet D FrenchUNKNOWN Ovarian Cancer Association Consortium
Mar 29, 2016·Biomedicines·Arun K Nalla, Grant D Trobridge

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.